Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06530225 · ClinicalTrials.gov registry record
Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program
A clinical trial, sponsored by Xavier University of Louisiana..
- Not yet
- Registry status
- 75
- Enrollment target
NCT06530225: Clinical Trial study, sponsored by Xavier University of Louisiana..
NCT06530225 is a clinical trial that has not yet begun recruiting, run by Xavier University of Louisiana.. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06530225 has not yet begun recruiting, sponsored by Xavier University of Louisiana..
- NOT YET RECRUITING
- Registry status
- 75 participants
- Enrollment target
Study Summary
Though broadening PrEP (Pre-Exposure Prophylaxis) availability to Louisiana pharmacies addresses key access issues for Louisiana's population, there is no current baseline data which explore current pharmacist and pharmacies' capacity to effectively provide PrEP therapy to patients who meet PrEP prescribing criteria. This study aims to explore1) Louisiana pharmacist and pharmacy capacity to provide PrEP under a state-based collaborative practice agreement, 2) a validated pharmacist education system addressing health disparities in PrEP prescribing and 3) the impact of state pharmacy based policies on equitable PrEP prescribing. Our central hypothesis is pharmacist trained in PrEP prescribing focusing on health disparities and implicit bias education and working with mentors in an implementation framework will have an increase in equitable PrEP prescribing
Primary Outcome
Number of PrEP prescriptions dispensed from pharmacy (Scale PrEP prescription/1,000 total prescriptions in 30 day period)
Interventions
- OTHER Education and Mentoring for Prescribing Pharmacists
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2030-04-30 |
What is known before NCT06530225 opens enrollment
NCT06530225 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Education and Mentoring for Prescribing Pharmacists is the first listed.
NCT06530225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06530225 about?
NCT06530225 is a clinical study titled "Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program". Though broadening PrEP (Pre-Exposure Prophylaxis) availability to Louisiana pharmacies addresses key access issues for Louisiana's population, there is no current baseline data which explore current pharmacist and pharmacies' capacity to effectively provide PrEP therapy to patients who meet PrEP pre...
What is the current status of trial NCT06530225?
This trial is currently not yet recruiting. The enrollment target is 75 participants. The study started on 2026-05-01. Estimated completion is 2030-04-30.
What interventions are being tested in trial NCT06530225?
The interventions under investigation include: Education and Mentoring for Prescribing Pharmacists (OTHER).
Who is sponsoring clinical trial NCT06530225?
This trial is sponsored by Xavier University of Louisiana., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI